NSE filing, NSE: MEESHO. Summary written from the filing by ALFA Finder's alert engine.
Meesho Ltd: key numbers
- Share price
- ₹226.50
- Market cap
- ₹1,04,844 Cr
- Revenue (annual)
- ₹12,626 Cr
- Net profit (annual)
- ₹-1,358 Cr
- P/E (TTM)
- -87.3×Sector 62.0×
- Promoter holding
- 16.34%-0.07% QoQ
- FII holding
- 9.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meesho Ltd
All →Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Meesho Earnings Call Transcript: Key Takeaways
Meesho reported strong contribution margins driven by logistics efficiencies, but higher server costs and seasonal marketing spends limited overall operating leverage.
Meesho Results Update
Meesho reported Q2 FY27 NMV growth of 23% and narrowed net losses by 68% to ₹132 crore. Contribution margin rose to 6.0% of NMV.
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.
Meesho Q2 FY27 Results: Net Loss of ₹132.4 Cr, Loss Narrows
Meesho Ltd reported revenue from operations of ₹4,132 Cr (+34.4% YoY) and a net loss of ₹132.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹132.4 Cr
Meesho Employee Stock Options
Meesho Limited allotted 3,44,262 equity shares to employees following the exercise of vested stock options under the Company's ESOP 2024 Plan.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.